Antiviral Drugs - Global Market Outlook (2016-2022)

Antiviral Drugs - Global Market Outlook (2016-2022)

  • Published: February 2017
  • ID: SMRC16336

According to Stratistics MRC, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.

HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.

Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.
                  
Applications Covered:
• Hepatitis-B antivirals
• Hepatitis-C antivirals
• Herpes virus
• HIV antivirals
• Influenza
• Other Applications
o Pneumonia
o Flu

End-Users Covered:
• Ambulatory Surgical Centers
• Clinics
• Hospitals

Distribution Channels covered:
• Hospital Pharmacy Store
• Online Pharmacy
• Retail Pharmacy Store

Product Types Covered:
• Generic Drugs
• Branded Drugs

Action Mechanisms covered:
• Nucleotide polymerase inhibitor
• Protease inhibitors
• Reverse transcriptase inhibitors
• Other Action Mechanisms

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary    
      
2 Preface  
   
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Application Analysis  
 3.7 Product Analysis   
 3.8 Emerging Markets   
 3.9 Futuristic Market Scenario  
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Antiviral Drugs Market, By Application 
 5.1 Introduction   
 5.2 Hepatitis-B antivirals  
 5.3 Hepatitis-C antivirals  
 5.4 Herpes virus   
 5.5 HIV antivirals   
 5.6 Influenza    
 5.7 Other Applications   
  5.7.1 Pneumonia  
  5.7.2 Flu   
      
6 Global Antiviral Drugs Market, By End-User 
 6.1 Introduction   
 6.2 Ambulatory Surgical Centers  
 6.3 Clinics    
 6.4 Hospitals    
      
7 Global Antiviral Drugs Market, By Distribution Channels
 7.1 Introduction   
 7.2 Hospital Pharmacy Store  
 7.3 Online Pharmacy   
 7.4 Retail Pharmacy Store  
      
8 Global Antiviral Drugs Market, By Product Type 
 8.1 Introduction   
 8.2 Generic Drugs   
 8.3 Branded Drugs   
      
9 Global Antiviral Drugs Market, By Action Mechanism
 9.1 Introduction   
 9.2 Nucleotide polymerase inhibitor 
 9.3 Protease inhibitors   
 9.4 Reverse transcriptase inhibitors 
 9.5 Other Action Mechanisms  
      
10 Global Antiviral Drugs Market, By Geography 
 10.1 North America   
  10.1.1 US   
  10.1.2 Canada   
  10.1.3 Mexico   
 10.2 Europe    
  10.2.1 Germany   
  10.2.2 France   
  10.2.3 Italy   
  10.2.4 UK   
  10.2.5 Spain   
  10.2.6 Rest of Europe  
 10.3 Asia Pacific   
  10.3.1 Japan   
  10.3.2 China   
  10.3.3 India   
  10.3.4 Australia   
  10.3.5 New Zealand  
  10.3.6 Rest of Asia Pacific  
 10.4 Rest of the World   
  10.4.1 Middle East  
  10.4.2 Brazil   
  10.4.3 Argentina  
  10.4.4 South Africa  
  10.4.5 Egypt   
      
11 Key Developments    
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers  
 11.3 New Product Launch  
 11.4 Expansions   
 11.5 Other Key Strategies  
      
12 Company Profiling    
 12.1 Abbott Laboratories   
 12.2 AbbVie, Inc.   
 12.3 Aurobindo Pharma   
 12.4 Bristol-Myers-Squibb  
 12.5 Cipla    
 12.6 Dr. Reddy’s Laboratories Ltd  
 12.7 F. Hoffmann-La Roche AG  
 12.8 Gilead Sciences   
 12.9 GlaxoSmithKline plc.  
 12.10 Johnson and Johnson  
 12.11 MedImmune/AstraZeneca  
 12.12 Merck & Co   
 12.13 Mylan N.V.   
 12.14 Roche Diagnostics   
 12.15 Schering-Plough   
 12.16 Teva Pharmaceutical Industries Ltd. 


List of Tables     
1 Global Antiviral Drugs Market Outlook, By Region (2014-2022) ($MN)
2 Global Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
3 Global Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
4 Global Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
5 Global Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
6 Global Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
7 Global Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
8 Global Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
9 Global Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
10 Global Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
11 Global Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
12 Global Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
13 Global Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
14 Global Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
15 Global Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
16 Global Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
17 Global Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
18 Global Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
19 Global Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
20 Global Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
21 Global Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
22 Global Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
23 Global Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
24 Global Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
25 Global Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
26 Global Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
27 North America Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
28 North America Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
29 North America Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
30 North America Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
31 North America Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
32 North America Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
33 North America Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
34 North America Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
35 North America Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
36 North America Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
37 North America Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
38 North America Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
39 North America Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
40 North America Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
41 North America Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
42 North America Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
43 North America Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
44 North America Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
45 North America Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
46 North America Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
47 North America Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
48 North America Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
49 North America Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
50 North America Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
51 North America Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
52 North America Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
53 Europe Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
54 Europe Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
55 Europe Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
56 Europe Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
57 Europe Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
58 Europe Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
59 Europe Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
60 Europe Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
61 Europe Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
62 Europe Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
63 Europe Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
64 Europe Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
65 Europe Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
66 Europe Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
67 Europe Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
68 Europe Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
69 Europe Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
70 Europe Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
71 Europe Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
72 Europe Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
73 Europe Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
74 Europe Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
75 Europe Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
76 Europe Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
77 Europe Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
78 Europe Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
79 Asia Pacific Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
80 Asia Pacific Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
81 Asia Pacific Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
82 Asia Pacific Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
83 Asia Pacific Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
84 Asia Pacific Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
85 Asia Pacific Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
86 Asia Pacific Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
87 Asia Pacific Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
88 Asia Pacific Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
89 Asia Pacific Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
90 Asia Pacific Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
91 Asia Pacific Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
92 Asia Pacific Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
93 Asia Pacific Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
94 Asia Pacific Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
95 Asia Pacific Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
96 Asia Pacific Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
97 Asia Pacific Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
98 Asia Pacific Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
99 Asia Pacific Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
100 Asia Pacific Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
101 Asia Pacific Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
102 Asia Pacific Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
103 Asia Pacific Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
104 Asia Pacific Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)
105 RoW Antiviral Drugs Market Outlook, By Country (2014-2022) ($MN)
106 RoW Antiviral Drugs Market Outlook, By Application (2014-2022) ($MN)
107 RoW Antiviral Drugs Market Outlook, By Hepatitis-B antivirals (2014-2022) ($MN)
108 RoW Antiviral Drugs Market Outlook, By Hepatitis-C antivirals (2014-2022) ($MN)
109 RoW Antiviral Drugs Market Outlook, By Herpes virus (2014-2022) ($MN)
110 RoW Antiviral Drugs Market Outlook, By HIV antivirals (2014-2022) ($MN)
111 RoW Antiviral Drugs Market Outlook, By Influenza (2014-2022) ($MN)
112 RoW Antiviral Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
113 RoW Antiviral Drugs Market Outlook, By Pneumonia (2014-2022) ($MN)
114 RoW Antiviral Drugs Market Outlook, By Flu (2014-2022) ($MN)
115 RoW Antiviral Drugs Market Outlook, By End-Users (2014-2022) ($MN)
116 RoW Antiviral Drugs Market Outlook, By Ambulatory Surgical Centers (2014-2022) ($MN)
117 RoW Antiviral Drugs Market Outlook, By Clinics (2014-2022) ($MN)
118 RoW Antiviral Drugs Market Outlook, By Hospitals (2014-2022) ($MN)
119 RoW Antiviral Drugs Market Outlook, By Distribution Channels (2014-2022) ($MN)
120 RoW Antiviral Drugs Market Outlook, By Hospital Pharmacy Store (2014-2022) ($MN)
121 RoW Antiviral Drugs Market Outlook, By Online Pharmacy (2014-2022) ($MN)
122 RoW Antiviral Drugs Market Outlook, By Retail Pharmacy Store (2014-2022) ($MN)
123 RoW Antiviral Drugs Market Outlook, By Product Type (2014-2022) ($MN)
124 RoW Antiviral Drugs Market Outlook, By Generic Drugs (2014-2022) ($MN)
125 RoW Antiviral Drugs Market Outlook, By Branded Drugs (2014-2022) ($MN)
126 RoW Antiviral Drugs Market Outlook, By Action Mechanism (2014-2022) ($MN)
127 RoW Antiviral Drugs Market Outlook, By Nucleotide polymerase inhibitor (2014-2022) ($MN)
128 RoW Antiviral Drugs Market Outlook, By Protease inhibitors (2014-2022) ($MN)
129 RoW Antiviral Drugs Market Outlook, By Reverse transcriptase inhibitors (2014-2022) ($MN)
130 RoW Antiviral Drugs Market Outlook, By Other Action Mechanisms (2014-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials